Neonatal exposure to estradiol-17β modulates tumour necrosis factor alpha and cyclooxygenase-2 expression in brain and also in ovaries of adult female rats by Shridharan, R.N. et al.
Horm Mol Biol Clin Invest 2016; aop
*Corresponding author: Dr. Vijayakumar Govindaraj, Research 
Associate, Department of Biochemistry, Indian Institute of Science, 
Bangalore 560012, India, Phone: +91-80-22932308,  
Fax: +91-080-23600814, E-mail: vijaygovindaraj@biochem.iisc.ernet.in; 
vijaygovindaraj@gmail.com
Radhika Nagamangalam Shridharan and SitiKantha Sarangi: 
Department of Microbiology and Biotechnology, Bangalore 
University, Bangalore, India
Harshini Krishnagiri and Addicam Jagannadha Rao: Department of 
Biochemistry, Indian Institute of Science, Bangalore, India
Radhika Nagamangalam Shridharan, Harshini Krishnagiri, Vijayakumar Govindaraj*, 
SitiKantha Sarangi and Addicam Jagannadha Rao
Neonatal exposure to estradiol-17β modulates 
tumour necrosis factor alpha and cyclooxygenase-2 
expression in brain and also in ovaries of adult 
female rats
DOI 10.1515/hmbci-2015-0072
Received December 8, 2015; accepted January 14, 2016
Abstract: The sexually dimorphic organization in perina-
tal rat brain is influenced by steroid hormones. Exposure 
to high levels of estrogen or endocrine-disrupting com-
pounds during perinatal period may perturb this pro-
cess, resulting in compromised reproductive physiology 
and behavior as observed in adult In our recent observa-
tion neonatal exposure of the female rats to estradiol-17β 
resulted in down-regulation of TNF-α, up-regulation of 
COX-2 and increase in SDN-POA size in pre-optic area in 
the adulthood. It is known that the control of reproduc-
tive performance in female involves a complex interplay 
of the hypothalamus, pituitary, and ovary. The present 
study was undertaken to understand the possible molecu-
lar mechanism involved in changes observed in the ovar-
ian morphology and expression of selected genes in the 
ovary. Administration of estradiol-17β (100 μg) on day 
2 and 3 after birth revealed up-regulation of ER-α, ER-β, 
COX-2 and down-regulation of TNF-α expression. Also 
the decrease in the ovarian weight, altered ovarian mor-
phology and changes in the 2D protein profiles were also 
seen. This is apparently the first report documenting that 
neonatal estradiol exposure modulates TNF-α and COX-2 
expression in the ovary as seen during adult stage. Our 
results permit us to suggest that cues originating from 
the modified brain structure due to neonatal exposure of 
estradiol-17β remodel the ovary at the molecular level in 
such a way that there is a disharmony in the reproductive 
function during adulthood and these changes are peren-
nial and can lead to infertility and changes of reproductive 
behavior.
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Introduction
In rodents, the sexual differentiation of the brain occurs 
during critical period (first 2 weeks after birth) [1]. The 
organization of brain sex differences during this critical 
period is important for adult reproductive function [1, 2]. 
Studies have shown that administration of estradiol-17β or 
compounds with estrogenic activity to newborn rats during 
critical period results in irreversible masculinization as 
well as defeminization in the brain resulting in abnormal 
sexual behavior as adults [1, 3–6]. Recently we observed 
that neonatal exposure to estradiol-17β in the female rat 
resulted in up-regulation of COX-2 and increased size of 
SDN-POA compared to control during adulthood [7]. Our 
data supported the fact that estradiol-17β plays critical 
role in the defeminization and masculinzation of the rat 
brain. It is imperative to study the contributing factors to 
monitor the expression of selected genes associated with 
synaptogenesis, an important process committed to the 
structural changes in the brain, in order to understand the 
long-term ramifications on the ovarian dysfunction [8, 9]. 
Our recent study showed that neonatal estradiol exposure 
modulate synaptogenesis related genes such as TNF-α 
and COX-2 in female rat POA during adulthood [7]. It is 
important to note that these genes are not only involved 
in synaptogenesis and sex difference, but also shown to 
have a role in oocyte maturation and ovulation. Consider-
ing the fact that the final target is the ovary for the hormo-
nal action in terms of anatomic integrity as well as sexual 
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receptivity, it was of interest to examine the changes in the 
ovary following neonatal administration of estradiol-17β. 
In the present work, we monitored the effect of neonatal 
administration of estradiol-17β to new born female rats on 
day 2 and 3 after birth as assessed on postnatal day 120 
on ovarian histology and expression of selected genes and 
proteomic profile.
Methods
Animals and treatment
Pups born to timed pregnant Wistar rats were housed at the Central 
Animal Facility, Indian Institute of Science, Bangalore, India, under 
light: dark (12/12 h) cycle at 24 °C, 50% average relative humidity and 
access to food and water ad libitum. Animals were maintained in 
accordance with the guidelines issued by Institutional Animal Eth-
ics Committee (IAEC), Indian Institute of Science and the procedures 
employed in the study have been approved by the IAEC. New born 
female rats were administered 100 μg of estradiol-17β (E2; Sigma, St. 
Louis, MO, USA, Cat No.E8875, dissolved in 0.05 mL of sesame oil) 
by subcutaneous route after birth on day 2 (first injection) and day 
3 (second injection) with 24 h interval and control littermates were 
administered 0.05 mL of sesame oil [7]. The rats were allowed to grow 
normally and were sacrificed on day 120 during metestrus period 
by using excess CO2 in a euthanasia chamber and ovaries were dis-
sected, weighed and stored at −80 °C until further use.
Semi-quantitative reverse transcription polymerase 
chain reaction (RT-PCR)
Total RNA from the ovary was extracted using TRI reagent (Sigma 
Chemicals Co, MO, USA) according to manufacturer’s instructions. 
The integrity of the RNA was checked on 1% MOPS-HCHO agarose 
gel and the quantity of RNA was estimated spectrophotometrically. 
Reverse transcription of RNA and subsequent PCR were performed as 
described earlier [10]. The list of highly specific forward and reverse 
primers is given in Table 1. Gel electrophoresis was carried out by 
taking 30 μL of the PCR product on a 1.5% agarose gel containing 
0.5 μg/mL of Ethidium bromide, in 1X TBE buffer containing 45 mM 
Tris-borate and 0.5 mM EDTA. The difference in the intensities of the 
products following electrophoresis was analyzed using the Kodak 
Table 1: List of primers used in the study.
  Gene   Sequence 5′ →3′  
(F-Forward; R-Reverse)
  Length  Annealing 
temperature (°C)
1  CBR1   F- AAGGAGTCCATGCGAAAGAA  20   60 °C
    R- GCTCCTTCTTCTGGGCTTTT   20  
2  MK12   F- CCTGGAAAAGATGCTGGTGT   20  
    R- GAGGCTTGAAGCTGAGCACT  20  
3  GAPDH  F- CTCATGACCACAGTCCATGC   20  
    R- TTCAGCTCTGGGATGACCTT   20  
Electrophoresis and Gel Documentation Analysis System (EDAS-120) 
(Eastman Kodak Co., New York, USA). The expression levels of  specific 
transcripts were inferred upon normalizing their signal intensities to 
that of glyceraldehyde 3-phosphate-dehydrogenase (GAPDH), which 
served as an internal control in this semi-quantitative analysis.
Western blot analysis
Protein lysates were prepared from control and E2 treated ovarian 
samples by homogenization of the tissues in a hand held Teflon-glass 
homogenizer using RIPA buffer (50 mM Tris, 150 mM NaCl, 0.1% SDS, 
0.5% sodium deoxycholate, 1% Triton-X 100 and protease inhibitor 
cocktail from Roche Diagnostics GmbH, Mannheim, Germany). The 
homogenate was centrifuged at 2500 g at 4 °C for 10 min and the total 
protein in the supernatant was estimated spectrophotometrically by 
Lowry’s method [11]. From each group, 40 μg of protein was elec-
trophorsed on 10% sodium dodecyl sulfate polyacrylamide gel and 
Western blotting was carried out as described [10]. The primary anti-
bodies used were anti-ER-α (Cell Signalling Technology, Denver, MA, 
USA, Cat No. 8644, dilution- 1:500, MW 66 kDa), anti-ER-β (Abnova, 
Taipei City, Taiwan, Cat No. H00002100-M01, dilution-1:500, MW 
37 kDa), anti-COX-2 (Cell Signalling Technology, Denver, MA, USA, 
Cat No.12282, dilution-1:500, MW 74 kDa), anti-TNF-alpha (17 kDa) 
(a kind gift from Prof. Anjali Karande, Indian Institute of Science, 
Bangalore), and anti-GAPDH (Cell Signalling Technology, Denver, 
MA, USA, Cat No. 2118, dilution-1:2000, MW 37 kDa). Goat anti-rabbit 
(Cat No. NA934, GE Healthcare, NJ, USA) and goat anti-mouse (Cat 
No. NA931, GE Healthcare, NJ, USA) were used as secondary antibod-
ies at the dilution of 1:5000. Signal intensities of various bands were 
determined by using the Kodak Electrophoresis and Gel Documen-
tation Analysis System (EDAS-120, Eastman Kodak Co., New York, 
USA). The expression levels of the amplified products of interest were 
inferred upon normalising their signal intensities to that of GAPDH. 
Values so obtained were used to determine mean±SEM for a graphi-
cal representation.
Two-dimensional gel electrophoresis (2DE) and image 
analysis
Equal quantity of protein (250 μg) from control and treated ovaries 
were subjected to two dimensional electrophoresis as described [12]. 
The acetone precipitated protein was re-suspended in 250 μL of sam-
ple rehydration buffer (7  M Urea, 4% CHAPS, IPG buffer (Catalogue 
No.17600088, GE Healthcare, Piscataway, NJ, USA). Immobiline pH 
gradient (IPG) gel strips –13 cm (Catalogue No.17600088, GE Health-
care, Piscataway, NJ, USA) were rehydrated overnight in 250 μL of rehy-
dration buffer containing protein sample. Isoelectric focusing (IEF) 
was carried out in Ettan IPGPhor 3 (GE Healthcare, Piscataway, NJ, 
USA) at 500 V (Step and Hold) for 1 h, at 1000 V (Gradient) for 1 h, at 
8000 V (Gradient) and at 8000 V (Step and Hold) for 2 h and 20 min, 
respectively. After first dimension, the gel strips were equilibrated for 
15 min in SDS equilibration buffer (6 M urea, 50 mM Tris (pH 8.8), 30% 
v/v glycerol, 2% w/v SDS, 2% w/v DTT). Second dimension electropho-
resis was performed using 10% sodium dodecyl sulfate polyacrylamide 
gel. Gels were stained with coomassie blue R-250 and stained gels were 
scanned by HP ScanJet G3110 scanner and images were analyzed by 
Dymension 2D gel image analysis software (Syngene, Cambridge, UK). 
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Figure 1: Effect of neonatal exposure to oestrogen on body weight (A), ovarian weight (B) and morphology of ovary (C).
The data of the body and the ovarian weights from five animals per group are expressed as mean±SEM (*p < 0.05). There was no significant 
change in the body weight (A). Compared to controls, rats that were neonatally exposed to estradiol-17β had very small ovaries (B) with no 
clear signs of active oogenesis or ovulation (C). This was characterized by absence of corpus luteum, presence of cystic follicles with thick-
ened thecal layer and atretic granulosa cells and abundant stroma.
Spot intensity was quantified by the total spot volume normalization 
which involved triplicates for each group. The volume of protein spots 
with a change  > 1.5 (p  ≤  0.05) was considered to be significant.
Statistical analysis
Data in each experiment are presented as mean±SEM (n = 5 per group). 
Differences between groups were analyzed by the two-tailed Student’s 
t-test and p-values  < 0.05 were considered statistically significant.
Results
Morphology of the ovary
Administration of estradiol-17β to neonatal rats resulted 
in significant decrease in ovarian weight with no signifi-
cant change in the overall body weight (Figure 1A and B). 
Ovarian morphology was distinctly different across treat-
ment groups. Female rats neonatally exposed to estradiol-
17β had very smaller size ovary with no clear signs of active 
oogenesis or ovulation. Ovaries of neonatally exposed to 
E2 had numerous large antral-like follicles and degenerat-
ing oocytes. Microscopic examination of ovarian sections 
revealed that while the ovary of the control group had 
several follicles and corpora lutea the ovary from the 
treated group is small in size and no corpora lutea were 
seen (Figure 1C).
Analysis of mRNA levels of selected genes 
by RT-PCR
It can be seen from the results presented in Figure 2 that 
there was a significant increase in the expression of ERα, 
ERβ, COX2 and a significant decrease in the expression 
of TNF-α mRNA levels in the ovaries of E2 treated rats as 
observed on postnatal day 120 as assessed by RT-PCR. It 
can also be seen from the results presented in Figure 3 that 
there was a significant increase in the expression of ER-α, 
ER-β, COX-2 and a significant decrease in the expression of 
TNF-α protein levels as assessed by Western blot.
Proteomic analysis by two dimensional 
electrophoresis
Two-dimensional electrophoresis (2DE) was carried out as 
described in the methods section to identify differentially 
Brought to you by | New York University Bobst Library Technical Services
Authenticated
Download Date | 3/7/16 10:45 AM
4      Nagamangalam Shridharan et al.: Neonatal E2 on TNF-α and COX-2 levels in adult ovary
expressed proteins in control and neonatally estradiol-
17β administered ovary samples. A representative gel 
image has been given in Figure 4A. Analysis of gel images 
by Dymension 2D gel image analysis software revealed 
approximately 270 protein spots in each gel. There were 
no protein spots which were expressed as only specific for 
either control or E2 treated ovary. There were six protein 
spots (marked with the number) differentially expressed 
between control and E2 treated ovary in which three (spots 
1–3) were down-regulated and three (spots 4–6) were up-
regulated in E2 treated compared to control. The close-up 
images of differentially expressed proteins are presented 
in Figure 4B. The differentially expressed protein spots 
were subjected to in-gel digestion and MALDI-TOF/TOF 
analysis, and mass spectral data were submitted to a 
database search against the NCBInr database for protein 
identification using the Mascot search programme (http://
www.matrixscience.com). The identity of down-regulated 
and up-regulated proteins is presented in Table 2. The 
RT-PCR validation of two differentially expressed proteins 
such as carbonyl reductase 1 (CBR1) and mitogen-activated 
protein kinase 12 (MK12) is presented in Figure 5.
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Figure 2: mRNA expression patterns of ER-α, ER-β, TNF-α and COX-2 genes in the ovary.
RNA isolated from ovary of control and neonatally estradiol-17β treated female rats was reverse transcribed to cDNA and subjected to 
RT-PCR analysis with GAPDH as an internal control. Data from five animals per group was expressed as arbitrary densitometric units 
(mean±SEM, *p  < 0.05 compared with control).
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Figure 3: Western blot analysis for ER-α, ER-β, TNF-α and COX-2 in the ovary.
A total of 40 μg of protein each from control and estradiol-17β treated ovary was separated by 10% sodium dodecyl sulfate polyacrylamide 
gel electrophoresis and subjected to western blotting as mentioned in materials and methods section. Data from five animals per group 
was expressed as arbitrary densitometric units (mean±SEM).
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Discussion
We previously demonstrated that estradiol-17β exposure 
during early postnatal life disrupts the expression of 
synaptogenesis related genes in preoptic area [7]. In the 
present study, using the same animal model, the increase 
in expression of ER-α, ER-β, COX-2 and down-regulation of 
TNF-α, alterations in ovarian morphology in the ovary of 
neonatally estradiol-17β treated female rats was observed. 
In our previous study the decreased expression of ER-α 
and ER-β was observed in pre-optic area of neonatally 
estradiol-17β treated animals [7]. It is known that both 
ER-α and ER-β are critically important for sexual differ-
entiation of the brain [13] and ER-β which is important in 
inducing a luteinizing hormone (LH) surge by oestrogen, 
typical of female estrous cycle, was decreased significantly 
in the hypothalamus, which is the main tissue in initiat-
ing cyclicity [7]. Our unpublished data show that serum 
estradiol level was  not  significantly different between 
control (28.31±1.30  pg/mL) and estradiol treated groups 
(24±4.30 pg/mL) and are comparable to values reported in 
the literature (25–35 pg/mL) for the adult animals [14]. The 
reason for this discrepancy between increased expression 
of receptor and no significant change in serum estradiol 
levels may be due to epigenetic or other post transcrip-
tional mechanisms. Studies have shown that epigenetic 
regulation of genes is involved in the control of sexual 
differentiation of the female brain [15]. During postnatal 
development, the neonatal estradiol treatment may have 
lasting effect on oestrogen receptors expression mediated 
by DNA methylation of its promoter through long-term 
transcriptional control by altering protein-DNA interac-
tions. It is also possible that when the level of ligand is 
drastically reduced the system responds to sequester 
whatever the ligand is available by increasing the expres-
sion of the corresponding receptor [16].
The control of reproductive cyclicity and ovulation 
is based on interaction of oestrogen with hypothalamus 
and pituitary via feedback mechanisms by influencing 
the cyclic secretion of LH and FSH [17]. Some studies have 
reported that neonatal estradiol or androgen induced ste-
rility with increased prolactin secretion [18, 19]. We wish 
to point out that the level of estradiol (100 μg) adminis-
tered in this study is not so high as to completely abolish 
FSH and LH producing cells and replaced by prolactin 
(PRL) producing cells. The level of estradiol administered 
is high but the duration of start of treatment and sacrifice 
of animals is 120  days and considering the long interval 
it is unlikely that high concentration of serum estradiol 
remains high. There is an alteration in responsiveness of 
hypothalamus and pituitary and it is unlikely the effects 
seen are due to high levels of PRL. Also it is essential to note 
that the alpha foeto-protein concentration is high in new 
born animals [20] will sequester E2 and only small percent-
age of injected estradiol enters in to the brain. And this is 
the reason why such high concentration of estradiol had to 
be injected. It is very important to note that studies which 
showed the effects of estrogenization and androgenization 
on both the dopaminergic and serotoninergic control of 
prolactin secretion are qualitatively different. The effect 
of drugs (dopaminergic and serotoninergic blockers) that 
alters dopaminergic versus serotoninergic effects on pro-
lactin secretion varies depending on whether the sterility 
was induced by testosterone or estradiol [20]. Also studies 
demonstrated that more than two to three times as many 
prolactin-expressing neurons from female hypothalamus 
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Figure 4: A representative 2-DE gel image of proteins profile of control and neonatally estradiol-17β treated rats (A).
Proteins were subjected to iso-electric focusing in the first dimension using 13 cm IPG strips (pH 4–7), followed by separation on 10% SDS-
PAGE gels in the second dimension (molecular weight 200–10 kDa range). The 2-DE gel was stained with Coomassie Brilliant Blue. Magni-
fied images of differentially expressed protein spots indicated by dark rectangles with arrow mark (B).
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survive when compared to those derived from male hypo-
thalamus, and this indicate that the changes are independ-
ent of gonadal steroids [21]. The current understanding 
neuronal basis of prolactin secretion in sexual differentia-
tion require further investigations.
A very interesting observation in the present study 
was a drastic decrease in the expression of TNF-α. It is 
documented that E2 modulates the expression of TNF-α 
in the ovary and TNF-α has a very important role in the 
regulation of ovarian follicle atresia as well as in corpus 
luteum function (i.e. granulosa-cell proliferation and ster-
oidogenesis) [22]. TNF-α is suggested to act as a survival/
proliferating factor in the follicle of porcine ovaries. Also 
the expression of TNFR2 (TNF-α receptor) disappeared in 
ovarian follicles during follicular atresia [23]. Based on 
these findings it suggested that TNF-α acts as a survival 
factor for ovarian follicles. The increase in the expression 
of COX-2 gene in POA has been considered as a parameter 
to conclude that the animals have responded to estradiol-
17β administration and also exhibit masculinization of 
spine density in the female brain [1, 8, 24]. Similar to the 
observation made in the brain, in the present study up-reg-
ulation of COX-2 expression was observed in the estradiol-
17β treated ovary. It is known that COX-2 is a rate-limiting 
enzyme during prostaglandin (PGE2) synthesis and it is 
expressed in all female reproductive organs and COX-2 has 
been shown to play a key role in the regulation of ovula-
tion [25]. COX-2 has been shown to be induced by factors 
such as tumour promoters, growth factors, cytokines, and 
mitogens in different cell types [26]. Over-expression of 
COX-2 has been associated with pathogenesis of many dis-
eases such as multiple epithelial cancers and colon cancer 
and multiple sclerosis, neurodegenerative diseases, and 
heart infarction [25, 27]. In polycyctic ovarian syndrome 
(PCOS), the elevated expression of COX-2 in theca layer of 
ovarian follicles has been reported with increased in the 
diameter of this layer due to the ability of COX-2 to stimu-
late cell proliferation, angiogenesis [28] and consequence 
of this may induce anovulation. Overexpression of COX-2 
has shown to stimulate the loss of basement membrane of 
ovarian surface epithelia which is important for ovulation 
[29]. Studies on female COX-2 or PGE2-null mice showed 
diminished ovulation, and exhibit irregular cumulus 
expansion and animals were infertile [30, 31]. In addition 
to its important role in ovulation, experimental evidences 
show that COX-2 contributes to proliferation, invasion and 
metastasis in several tumors [32, 33] and it was found to be 
over expressed in pre-neoplastic changes of the ovarian 
surface epithelium [25, 29]. Based on these findings it sug-
gested that the increased COX-2 and reduced TNF-α expres-
sion are associated with altered ovarian morphology.Ta
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Two-dimensional electrophoresis analysis of ovaries 
of control and neonatally estradiol treated rats revealed 
six differentially expressed proteins as shown in Table 2. 
One of the down-regulated proteins such as aldo-keto 
reductase family 1 (AKR1) is an enzyme which has been 
shown to play an essential role in the metabolism of all 
steroid hormones. This enzyme catalyses the reduction 
of progesterone to the inactive form 20-alpha-hydroxy-
progesterone and it is expressed in the ovary throughout 
the estrous cycle [34]. Another down-regulated protein 
called carbonyl reductase 1 (Cbr1) is a NADPH-dependent 
oxidoreductase specific for carbonyl compounds such as 
quinines and xenobiotics. 20 beta-hydroxysteroid dehy-
drogenase (HSD)/carbonyl reductase-like (Cbr1) converts 
17a-hydroxyprogesterone (17-P) to 17a,20beta-dihydroxy-
progesterone [35]. Gastrotopin (fatty acid binding protein 
family6- FABP6) plays a role in fatty acid uptake, trans-
port, and metabolism. FABP6 mRNA and protein has 
been found to be expressed in luteal cells of the rat ovary 
and FABP6 has been shown to have variety of function 
including steroid hormone metabolism [36]. FABP6 has 
been shown as one of the downstream targets of LH surge 
induced transcription factor called RUNX2 (runt-related 
transcription factor 2) [36]. The biological function of 
LIX1-like protein has not been elucidated, the other two 
up-regulated proteins mitogen-activated protein kinase 
and 40s ribosomal protein S15a are shown to be involved 
in acceleration of ovarian tumourigenesis and metastasis 
via the MAP kinase signal pathway [37]. Further studies 
are warranted to determine the significance of the effect 
of neonatal estradiol exposure on the up and down regu-
lated proteins in the ovary.
In conclusion, our results suggest that although the 
main targets for the neonatal administration of E2 are the 
different regions of brain such as pre-optic area, hypo-
thalamus and pituitary, the changes observed for the first 
time in TNF-α and COX-2 levels suggest a possible role of 
these genes acting directly or indirectly on the adult ovary 
resulting in a remarkable change in morphology which 
subsequently leads to infertility.
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